new_0222_0402|IMRX|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0402|IMRX|1|Immuneering Corp Total Current Assets (Quarterly) (USD)|Immuneering Corp Cash and Short Term Investments (Quarterly) (USD)|Immuneering Corp Inventories (Quarterly) (USD)|Immuneering Corp Net PP&E (Quarterly) (USD)|Immuneering Corp Goodwill and Intangibles (Quarterly) (USD)|Immuneering Corp Total Liabilities (Quarterly) (USD)|Immuneering Corp Total Current Liabilities (Quarterly) (USD)|Immuneering Corp Total Long Term Liabilities (Quarterly) (USD)|Immuneering Corp Total Deposits (Quarterly) (USD)|Immuneering Corp Book Value (Quarterly) (USD)|Immuneering Corp Retained Earnings (Quarterly) (USD)|Immuneering Corp Treasury Stock (Quarterly) (USD)|Immuneering Corp EV to Revenues|Immuneering Corp EV to Earnings|Immuneering Corp EV to Free Cash Flow|Immuneering Corp EV to Assets (Quarterly)|Immuneering Corp PS Ratio|Immuneering Corp PE Ratio|Immuneering Corp Price to Book Value|Immuneering Corp PEG Ratio|Immuneering Corp Debt to Equity Ratio|Immuneering Corp Dividend Yield|Immuneering Corp Shareholder Yield (TTM)|Immuneering Corp Percent of Shares Outstanding Short|Immuneering Corp Total Receivables (Quarterly) (USD)|Immuneering Corp Total Payables (Quarterly) (USD)|Immuneering Corp Total Capital Stock (Quarterly) (USD)|Immuneering Corp Return on Invested Capital|Immuneering Corp Quality Ratio Score|Immuneering Corp Momentum Score|Immuneering Corp Beta (1Y)|Immuneering Corp Sustainable Growth Rate (TTM)|Immuneering Corp Institutional Investor Ownership Percentage|Immuneering Corp Average Diluted Shares Outstanding (Quarterly)|Immuneering Corp Total Employees (Annual)|Immuneering Corp EPS Diluted (Quarterly) (USD)|Immuneering Corp SG&A Expense (Quarterly) (USD)|Immuneering Corp Shares Outstanding|Immuneering Corp Repurchase of Capital Stock (Quarterly) (USD)|Immuneering Corp Ordinary Shares Number (Quarterly)|Immuneering Corp Payout Ratio|Immuneering Corp Quick Ratio (Quarterly)|Immuneering Corp Normalized Diluted EPS (Quarterly) (USD)|Immuneering Corp Stock Buybacks (Quarterly) (USD)|Immuneering Corp Effective Tax Rate (TTM)|Immuneering Corp Return on Equity|Immuneering Corp Net Income (TTM) (USD)|Immuneering Corp Revenue (TTM) (USD)|Immuneering Corp Dividend Per Share (Quarterly) (USD)|Immuneering Corp Revenue (Quarterly) (USD)|Immuneering Corp Gross Profit (Quarterly) (USD)|Immuneering Corp Pre-Tax Income (Quarterly) (USD)|Immuneering Corp Net Income (Quarterly) (USD)|Immuneering Corp Net Interest Income (Quarterly) (USD)|Immuneering Corp Price (USD)|Immuneering Corp Total Return Price (USD)|Immuneering Corp Enterprise Value (USD)|Immuneering Corp 30-Day Average Daily Volume|Immuneering Corp 1 Year Price Returns (Daily)|Immuneering Corp Short Interest|Immuneering Corp PE Ratio (Forward)|Immuneering Corp PE Ratio (Forward 1y)|Immuneering Corp PS Ratio (Forward)|Immuneering Corp PS Ratio (Forward 1y)|Immuneering Corp Quarterly EPS Estimates (USD)|Immuneering Corp Quarterly Revenue Estimates (USD)|Immuneering Corp Quarterly EPS Surprise|Immuneering Corp Quarterly Revenue Surprise|Immuneering Corp Quarterly Actual EPS (USD)|Immuneering Corp Quarterly Actual Revenue (USD)|Immuneering Corp Revenue Estimates for Current Fiscal Year (USD)|Immuneering Corp Revenue Estimates for Next Fiscal Year (USD)|Immuneering Corp Price Target (USD)|Immuneering Corp Consensus Recommendation|Immuneering Corp Price Target Num Estimates|Immuneering Corp EPS Estimates for Current Fiscal Year (USD)|Immuneering Corp EPS Estimates for Next Fiscal Year (USD)|Immuneering Corp Research and Development Expense (Quarterly) (USD)|Immuneering Corp Reconciled Depreciation (Quarterly) (USD)|Immuneering Corp Non-Operating Interest Expense (Quarterly) (USD)|Immuneering Corp Land and Improvements (Quarterly) (USD)|Immuneering Corp Buildings and Improvements (Quarterly) (USD)|Immuneering Corp Other Properties (Quarterly) (USD)|Immuneering Corp Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0402|IMRX|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0402|IMRX|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly|monthly|quarterly|quarterly|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0402|IMRX|5|91|91||91||91|91|91||91|91||1.43971631206||1.43971631206||1.43971631206||1.4387755102||91|1.43971631206||15.4166666667|91|91|91||92||||30.6666666667|91.3333333333|92|91.3333333333|91.3333333333|20||91|91|91|91.3333333333||||91|91||91.3333333333|91.3333333333|91.3333333333|91.3333333333|91.3333333333|1.43971631206|1.43971631206|1.43971631206|1.4375||15.4166666667|||1.44117647059|1.44117647059|91.5|91.5|92|92|92|92|22.8571428571|26.6666666667|20|11.4285714286|20|17.7777777778|20|91.3333333333|91.3333333333||||91|91||
new_0222_0402|IMRX|6|3|3||3||3|3|3||3|3||141||141||141||98||3|141||12|3|3|3||1||||6|6|1|6|6|5||3|3|3|6||||3|3||6|6|6|6|6|141|141|141|112||12|||34|34|6|6|1|1|1|1|7|6|8|14|8|9|8|6|6||||3|3||
new_0222_0402|IMRX|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0402|IMRX|202003||||||||||||||||||||||||||||||||||13.5114||-0.2369|0.644||||||-0.2369|||||||0.483|0.228|-3.2007|-3.2007|0.0385||||||||||||||||||||||||2.8233|0.0152|||||||
new_0222_0402|IMRX|202006||||||||||||||||||||||||||||||||||13.5114||-0.2667|0.629||||||-0.2667|||||||0.4808|0.2438|-3.6038|-3.6042|0.0025||||||||||||||||||||||||3.221|0.016|||||||
new_0222_0402|IMRX|202009||||||||||||||||||||||||||||||||||13.5114||-0.3256|0.699||||||-0.3256|||||||0.6826|0.3676|-4.3993|-4.3991|0.0011||||||||||||||||||||||||4.069|0.0159|||||||
new_0222_0402|IMRX|202012|37.7312|37.0902||0.6775||60.9045|2.2559|58.6486||-22.4814|-25.7376||||||||||||||0.5001|1.4805|0.005|||||||13.5114||-0.4319|1.138|||23.8894||16.6635|-0.4319||||-17.0399|2.3115||0.6651|0.1918|-5.8361|-5.8359|0.0005||||||||||||||||||||||||4.8905|0.0322||||0.6131|0.1931||
new_0222_0402|IMRX|202103|32.1828|30.9337||0.6601||3.2822|2.7581|0.5241||29.575|-31.9673||||||||||||||0.4924|1.3688|0.0135|||||||13.5114||-0.46|1.184|||23.8894||11.3941|-0.46||||-20.0688|2.5767||0.7482|0.339|-6.2297|-6.2297|0.0064||||||||||||||||||||||||5.391|0.0339||||0.5881|0.2097||
new_0222_0402|IMRX|202106|51.4369|50.2451||0.6448||88.2279|4.832|83.3959||-35.1858|-39.955||137.4382||-17.5383||102.7991|||||||0.6683|0.4951|1.4325|0.0053||2||||26.8677|23.8894|34|-0.3344|1.34|24.3894||23.8894||10.5009|-0.3344||||-24.4523|2.7559||0.66|0.3414|-7.9873|-7.9877|0.0033|17.59|17.59|378.7644|||170524|||||-1.735|0.4833|7.2046|36.5609|-1.61|0.66|2.1157|1.8701|43.6667|1.5|3|-3.525|-2.28|6.992|0.0351||||0.5628|0.2295|24.47|
new_0222_0402|IMRX|202109|153.3108|149.478||0.6186||5.7488|5.2668|0.482||158.2936|-48.489||210.9916|-18.8608|-19.8587|3.2868|179.7357||4.3505|||||2.1828|0.4714|1.7952|0.0259|-87.825|1|||-87.825|70.414|18.2864|36|-0.47|2.599|25.9381||25.9381||28.4707|-0.47|-120.3188||-87.825|-28.5873|2.5554||0.4821|0.263|-8.5341|-8.5341|0.0174|26.55|26.55|539.1786|167823.9667||566182|||||-0.625|0.7|24.8|-31.1243|-0.47|0.4821|2.786|1.8316|43.6667|1.5|3|-3.5|-2.23|6.2075|0.0376||||0.5372|0.2408|27.1|22.63
new_0222_0402|IMRX|202112|||||||||||||105.6493||-9.9438||109.4661||2.6499|||||4.0881|||||||||69.6503||||||||||||||||||||||16.17|16.17|269.9815|78791.7||1075993|||238.4987|267.1291|-0.39|0.5355|||||2.4444|1.717|38.6667|1.5|3|-3.4467|-2.0733||||||||10|8.33
new_0222_0402|IMRX|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.4|0.4298||||||||||||||||||||
new_0222_0402|IMRX|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.4833|0.4243||||||||||||||||||||
new_0222_0402|IMRX|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.4833|0.419||||||||||||||||||||
new_0222_0402|IMRX|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.55|0.4143||||||||||||||||||||